“One of the major obstacles in increasing access to psychedelic therapy is an acute shortage of therapists who have the education, knowledge and resources both from a psychological and psychedelic perspective to provide the necessary support and guidance to patients,” said David Harder, co-CEO of ATMA. “This training program provides an accredited base of understanding for therapists who are seeking information and therapy involving psychedelics.”
Megan McElheran, CEO of Wayfound, a Calgary-based mental health service provider that’s been operating for 20 years, said the company felt “a client obligation to explore the research and clinical protocols related to psychedelic medicine.”
“Psychedelic treatment that includes psychotherapy has the potential to be a new frontier for psychology as we see that a potential paradigm shift is underway in mental health,” McElheran said. “Psychology has an essential role to play in this developing field and I am excited to participate in the training and capacity-building of our profession.”